Ono Pharmaceutical Co., Ltd. (TYO:4528)
1,541.00
-58.50 (-3.66%)
Apr 2, 2025, 3:30 PM JST
Ono Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 1, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Market Capitalization | 751,298 | 1,152,917 | 1,349,755 | 1,512,876 | 1,442,521 | 1,240,811 | Upgrade
|
Market Cap Growth | -36.23% | -14.58% | -10.78% | 4.88% | 16.26% | 11.27% | Upgrade
|
Enterprise Value | 740,321 | 1,065,259 | 1,255,982 | 1,465,094 | 1,366,726 | 1,156,658 | Upgrade
|
Last Close Price | 1599.50 | 2348.17 | 2565.88 | 2781.00 | 2570.02 | 2175.70 | Upgrade
|
PE Ratio | 10.17 | 9.01 | 11.97 | 18.79 | 19.13 | 20.78 | Upgrade
|
Forward PE | 11.10 | 10.24 | 10.81 | 13.49 | 17.11 | 19.62 | Upgrade
|
PS Ratio | 1.54 | 2.29 | 3.02 | 4.19 | 4.66 | 4.24 | Upgrade
|
PB Ratio | 0.92 | 1.44 | 1.81 | 2.29 | 2.25 | 2.18 | Upgrade
|
P/TBV Ratio | 1.75 | 1.57 | 2.01 | 2.56 | 2.55 | 2.50 | Upgrade
|
P/FCF Ratio | 8.55 | 10.81 | 8.75 | 26.86 | 21.54 | 18.61 | Upgrade
|
P/OCF Ratio | 8.29 | 10.42 | 8.46 | 24.47 | 19.50 | 16.73 | Upgrade
|
PEG Ratio | 1.39 | 1.39 | 1.39 | 0.81 | 1.40 | 2.83 | Upgrade
|
EV/Sales Ratio | 1.52 | 2.12 | 2.81 | 4.05 | 4.42 | 3.96 | Upgrade
|
EV/EBITDA Ratio | 6.68 | 5.97 | 7.50 | 11.40 | 11.93 | 12.58 | Upgrade
|
EV/EBIT Ratio | 8.43 | 6.65 | 8.37 | 13.22 | 13.84 | 14.88 | Upgrade
|
EV/FCF Ratio | 8.43 | 9.99 | 8.14 | 26.01 | 20.41 | 17.35 | Upgrade
|
Debt / Equity Ratio | 0.19 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | Upgrade
|
Debt / EBITDA Ratio | - | 0.05 | 0.05 | 0.07 | 0.08 | 0.09 | Upgrade
|
Debt / FCF Ratio | 1.76 | 0.08 | 0.06 | 0.16 | 0.14 | 0.13 | Upgrade
|
Asset Turnover | 0.49 | 0.56 | 0.55 | 0.49 | 0.44 | 0.44 | Upgrade
|
Inventory Turnover | 2.26 | 2.72 | 2.54 | 2.31 | 2.38 | 2.41 | Upgrade
|
Quick Ratio | 2.65 | 2.92 | 1.71 | 2.56 | 1.58 | 1.60 | Upgrade
|
Current Ratio | 3.55 | 3.99 | 2.81 | 4.27 | 2.64 | 2.47 | Upgrade
|
Return on Equity (ROE) | 9.18% | 16.56% | 16.02% | 12.39% | 12.49% | 10.59% | Upgrade
|
Return on Assets (ROA) | 5.56% | 11.16% | 11.57% | 9.32% | 8.69% | 7.31% | Upgrade
|
Return on Capital (ROIC) | 6.19% | 12.81% | 13.14% | 10.49% | 10.06% | 8.51% | Upgrade
|
Return on Capital Employed (ROCE) | 9.10% | 19.80% | 19.80% | 16.50% | 15.10% | 13.30% | Upgrade
|
Earnings Yield | 9.85% | 11.10% | 8.35% | 5.32% | 5.23% | 4.81% | Upgrade
|
FCF Yield | 11.70% | 9.25% | 11.43% | 3.72% | 4.64% | 5.37% | Upgrade
|
Dividend Yield | 4.99% | 3.41% | 2.73% | 2.01% | 1.95% | 2.07% | Upgrade
|
Payout Ratio | 0.00% | 29.05% | 26.38% | 34.36% | 29.76% | 38.15% | Upgrade
|
Buyback Yield / Dilution | 2.96% | 1.70% | 1.65% | 0.54% | 0.96% | 1.97% | Upgrade
|
Total Shareholder Return | 7.95% | 5.11% | 4.37% | 2.55% | 2.91% | 4.04% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.